Strides Pharma Science Limited — Board Meeting, 18-05-2026: Outcome of Board Meeting

Strides Pharma Science's Board approved audited consolidated financial results for the quarter and financial year ended March 31, 2026, posting a FY26 profit of Rs. 574.52 Cr. A final dividend of Rs. 5 per equity share (face value Rs. 10) was also declared, pending shareholder approval.